Verapamil Hydrochloride | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Verapamil Hydrochloride
EDQM

munit-sa-m-2025-04-14

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Verapamil Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 17 USDMF, 10 CEP/COS, 1 JDMF, 5 EU WC, 2 KDMF, 15 NDC API, 15 Listed Suppliers, $ API Reference Price

40 API Suppliers
17 USDMF
10 CEP/COS
1 JDMF
5 EU WC
2 KDMF
15 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

148 FDF Dossiers, 114 FDA Orange Book, 12 Europe, 6 Canada, 6 South Africa, 10 Listed Dossiers

148 FDF Dossiers
114 FDA Orange Book
12 Europe
6 Canada
6 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 180MG
CAPSULE, EXTENDED RELEASE;ORAL - 240MG
CAPSULE, EXTENDED RELEASE;ORAL - 360MG
CAPSULE, EXTENDED RELEASE;ORAL - 100MG
CAPSULE, EXTENDED RELEASE;ORAL - 200MG
CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 11 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 16 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 78 Coating Systems & Additives, 47 Controlled & Modified Release, 44 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 35 Solubilizers, 32 Granulation, 32 Direct Compression, 22 Taste Masking, 20 Lubricants & Glidants, 17 Film Formers & Plasticizers, 17 Topical, 16 Parenteral, 12 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 9 Empty Capsules, 9 Emulsifying Agents, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

78 Fillers, Diluents & Binders
78 Coating Systems & Additives
47 Controlled & Modified Release
44 Disintegrants & Superdisintegrants
36 Thickeners and Stabilizers
35 Solubilizers
32 Granulation
32 Direct Compression
22 Taste Masking
20 Lubricants & Glidants
17 Film Formers & Plasticizers
17 Topical
16 Parenteral
12 Co-Processed Excipients
11 Chewable & Orodispersible Aids
9 Empty Capsules
9 Emulsifying Agents
8 Rheology Modifiers
6 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

1 Data Compilation #PharmaFlow
18 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 26 Regulatory FDF Prices

1 US Medicaid Prescriptions
26 Regulatory FDF Prices

MARKET PLACE

15 APIs, 1 FDF Dossiers

15 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 Others

4 EDQM
1 Others

$ API Ref.Price (USD/KG) : 84 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1P0270000

02 1V0100000

03 1V0100018

04 1V0100026

filter CAS Number Reset all filters

4 All

01 1152-11-4

02 11794-55-4

03 161-25-6

04 1n/a

filter Reference Standard Reset all filters

4 All

01 1Papaverine hydrochloride

02 1Verapamil hydrochloride

03 1Verapamil impurity I

04 1Verapamil impurity M

Product Main Page

01

EDQM, Council of Europe

Papaverine hydrochloride

MAGHREB PHARMA

Not Confirmed

EDQM, Council of Europe

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Papaverine hydrochloride

CAS Number : 61-25-6

Quantity Per Vial : 25 mg

Sale Unit : 1

Order Code : P0270000

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Verapamil hydrochloride

MAGHREB PHARMA

Not Confirmed

EDQM, Council of Europe

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Verapamil hydrochloride

CAS Number : 152-11-4

Quantity Per Vial : 100 mg

Sale Unit : 1

Order Code : V0100000

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Verapamil impurity I

MAGHREB PHARMA

Not Confirmed

EDQM, Council of Europe

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Verapamil impurity I

CAS Number : 1794-55-4

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : V0100018

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Verapamil impurity M

MAGHREB PHARMA

Not Confirmed

EDQM, Council of Europe

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Verapamil impurity M

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : V0100026

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!